393 related articles for article (PubMed ID: 23994534)
21. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
22. Endometrial carcinoma in the baby boomer generation. Tumor characteristics and clinical outcome.
Elshaikh MA; Cattaneo R; Shah M; Patel S; Mahan M; Buekers T; Siddiqui F
Anticancer Res; 2013 Feb; 33(2):619-24. PubMed ID: 23393357
[TBL] [Abstract][Full Text] [Related]
23. Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002).
Park JY; Kim DY; Kim JH; Kim YM; Kim KR; Kim YT; Seong SJ; Kim TJ; Kim JW; Kim SM; Bae DS; Nam JH
Eur J Cancer; 2013 Mar; 49(4):868-74. PubMed ID: 23072814
[TBL] [Abstract][Full Text] [Related]
24. Comparison of outcomes in patients with early-stage mucinous endometrial cancer and those with endometrioid endometrial cancer, with and without adjuvant therapy.
Owusu-Darko S; Rauh-Hain JA; Horowitz NS; Goodman A; Schorge JO; Del Carmen MG
J Reprod Med; 2014; 59(11-12):527-33. PubMed ID: 25552123
[TBL] [Abstract][Full Text] [Related]
25. Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer.
Papanikolaou A; Kalogiannidis I; Goutzioulis M; Misailidou D; Makedos A; Vergote I; Makedos G
Arch Gynecol Obstet; 2006 May; 274(2):91-6. PubMed ID: 16518607
[TBL] [Abstract][Full Text] [Related]
26. Does hormonal therapy for fertility preservation affect the survival of young women with early-stage endometrial cancer?
Greenwald ZR; Huang LN; Wissing MD; Franco EL; Gotlieb WH
Cancer; 2017 May; 123(9):1545-1554. PubMed ID: 28026855
[TBL] [Abstract][Full Text] [Related]
27. Impact of ovarian preservation in women with endometrial cancer.
Lau HY; Twu NF; Yen MS; Tsai HW; Wang PH; Chuang CM; Wu HH; Chao KC; Chen YJ
J Chin Med Assoc; 2014 Jul; 77(7):379-84. PubMed ID: 24908183
[TBL] [Abstract][Full Text] [Related]
28. Does ovarian preservation have an effect on recurrence of early stage low-grade endometrial stromal sarcoma?
Karataşlı V; Çakır İ; Can B; Erkılınç S; Karadeniz T; Kuru O; Gökçü M; Sancı M
J Obstet Gynaecol; 2021 Jul; 41(5):797-802. PubMed ID: 33063586
[TBL] [Abstract][Full Text] [Related]
29. Influence of body mass index on clinicopathologic features, surgical morbidity and outcome in patients with endometrial cancer.
Akbayır O; Corbacıoglu Esmer A; Numanoglu C; Cılesız Goksedef BP; Akca A; Bakır LV; Kuru O
Arch Gynecol Obstet; 2012 Nov; 286(5):1269-76. PubMed ID: 22729137
[TBL] [Abstract][Full Text] [Related]
30. Survival Impact of Ovarian Preservation on Women With Early-Stage Endometrial Cancer: A Systematic Review and Meta-analysis.
Gu H; Li J; Gu Y; Tu H; Zhou Y; Liu J
Int J Gynecol Cancer; 2017 Jan; 27(1):77-84. PubMed ID: 27922977
[TBL] [Abstract][Full Text] [Related]
31. Temporal pattern of recurrence of stage I endometrial cancer in relation to histological risk factors.
Ben Arie A; Lavie O; Gdalevich M; Voldarsky M; Barak F; Schneider D; Levy T; Anteby E; Gemer O
Eur J Surg Oncol; 2012 Feb; 38(2):166-9. PubMed ID: 22056646
[TBL] [Abstract][Full Text] [Related]
32. Synchronous primary cancers of the endometrium and ovary in young women: a Korean Gynecologic Oncology Group Study.
Song T; Seong SJ; Bae DS; Suh DH; Kim DY; Lee KH; Lim MC; Lee TS
Gynecol Oncol; 2013 Dec; 131(3):624-8. PubMed ID: 24051220
[TBL] [Abstract][Full Text] [Related]
33. Tumour-free distance from serosa is a better prognostic indicator than depth of invasion and percentage myometrial invasion in endometrioid endometrial cancer.
Chattopadhyay S; Galaal KA; Patel A; Fisher A; Nayar A; Cross P; Naik R
BJOG; 2012 Sep; 119(10):1162-70. PubMed ID: 22804815
[TBL] [Abstract][Full Text] [Related]
34. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
[TBL] [Abstract][Full Text] [Related]
35. Patterns of recurrence in 1988 FIGO stage IC endometrioid endometrial cancer.
Long KC; Zhou Q; Hensley ML; Alektiar KM; Gomez J; Gardner GJ; Chi DS; Barakat RR; Abu-Rustum NR
Gynecol Oncol; 2012 Apr; 125(1):99-102. PubMed ID: 22112609
[TBL] [Abstract][Full Text] [Related]
36. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
[TBL] [Abstract][Full Text] [Related]
37. Impact of lymphadenectomy in uterine endometrioid carcinoma.
Huang CY; Ho CM; Chen YL; You SL; Chen CA; Cheng WF
Eur J Surg Oncol; 2013 Apr; 39(4):350-7. PubMed ID: 23462243
[TBL] [Abstract][Full Text] [Related]
38. Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancer.
Matsuo K; Cripe JC; Kurnit KC; Kaneda M; Garneau AS; Glaser GE; Nizam A; Schillinger RM; Kuznicki ML; Yabuno A; Yanai S; Garofalo DM; Suzuki J; St Laurent JD; Yen TT; Liu AY; Shida M; Kakuda M; Oishi T; Nishio S; Marcus JZ; Adachi S; Kurokawa T; Ross MS; Horowitz MP; Johnson MS; Kim MK; Melamed A; Machado KK; Yoshihara K; Yoshida Y; Enomoto T; Ushijima K; Satoh S; Ueda Y; Mikami M; Rimel BJ; Stone RL; Growdon WB; Okamoto A; Guntupalli SR; Hasegawa K; Shahzad MMK; Im DD; Frimer M; Gostout BS; Ueland FR; Nagao S; Soliman PT; Thaker PH; Wright JD; Roman LD
Gynecol Oncol; 2019 Oct; 155(1):39-50. PubMed ID: 31427143
[TBL] [Abstract][Full Text] [Related]
39. Receipt of vaginal brachytherapy is associated with improved survival in women with stage I endometrioid adenocarcinoma of the uterus: A National Cancer Data Base study.
Rydzewski NR; Strohl AE; Donnelly ED; Kanis MJ; Lurain JR; Nieves-Neira W; Strauss JB
Cancer; 2016 Dec; 122(23):3724-3731. PubMed ID: 27509082
[TBL] [Abstract][Full Text] [Related]
40. Multicenter analysis of recurrence and survival in stage IIIA endometrial cancer.
Havrilesky LJ; Secord AA; O'Malley DM; Broadwater G; Bae-Jump V; Cohn DE; Gehrig PA
Gynecol Oncol; 2009 Aug; 114(2):279-83. PubMed ID: 19446319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
